Michael A. Panzara - 18 Mar 2022 Form 3 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
Glenna Mileson, Attorney-in-fact for Michael Panzara
Issuer symbol
ATHA
Transactions as of
18 Mar 2022
Transactions value $
$0
Form type
3
Date filed
21 Mar 2022, 16:36
Previous filing
18 Feb 2022
Next filing
06 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATHA No securities are beneficially owned. 0 18 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATHA No securities are beneficially owned. 18 Mar 2022 Not Applicable 0 $0.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable.